CRL - Charles River Laboratories International Inc Stock Analysis
Charles River Laboratories International Inc (CRL) is a publicly traded company listed on the NYSE. It operates in the Diagnostics & Research industry, part of the broader Healthcare sector. The company has a market capitalization of 10.81B, generates annual revenue of 4.02B, and reports net income of -83.48M. As of the latest data, the stock is trading at 219.70 USD.
From a valuation and risk perspective, the stock presents the following profile: The P/E ratio is unavailable or not meaningful at this time. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. This stock does not currently pay a dividend. The stock exhibits higher volatility than the market, which may indicate greater risk and potential reward.
Analyst recommendation stands at Hold (3.95), indicating current market sentiment. Institutional ownership is reported at 104.49%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of 26.33%, trading within a 52-week range of 91.86 - 228.88.
CRL - Charles River Laboratories International Inc
219.70
Analyst Consensus
Hold 3.95
CRL – Analyst Rating Summary
- Strong Buy: 7
- Buy: 7
- Hold: 8
- Sell: 0
- Strong Sell: 0
- Total Analysts: 22
| Index: | S&P 500 | P/E: | - | EPS (ttm): | -1.55 | Insider Own: | 1.17% | Shs Outstand: | 49.22M | Perf Week: | -0.55% |
| Market Cap: | 10.81B | Forward P/E: | 19.97 | EPS next Y: | 11.00 | Insider Trans: | -0.21% | Shs Float: | 48.64M | Perf Month: | 12.54% |
| Income(ttm): | -83.48M | PEG: | 3.70 | EPS next Q: | 2.35 | Inst Own: | 104.49% | Short Float: | 5.29% | Perf Quarter: | 25.58% |
| Revenue(ttm): | 4.02B | P/S: | 2.69 | EPS this Y: | -0.76% | Inst Trans: | 2.19% | Short Ratio: | 2.77 | Perf Half Y: | 42.22% |
| Book/sh: | 69.20 | P/B: | 3.18 | EPS next Y: | 7.41% | ROA: | -1.08% | Short Interest: | 2.57M | Perf Year: | 26.33% |
| Cash/sh: | 4.22 | P/C: | 52.07 | EPS next 5Y: | 5.40% | ROE: | -2.32% | 52W Range: | 91.86 - 228.88 | Perf YTD: | 10.14% |
| Dividend Est.: | - | P/FCF: | 19.89 | EPS past 3/5Y: | -70.29% -47.65% | ROIC: | -1.38% | 52W High: | 228.88 -4.01% | Beta: | 1.63 |
| Dividend TTM: | - | Quick Ratio: | 1.10 | Sales past 3/5Y: | 4.59% 9.09% | Gross Margin: | 29.73% | 52W Low: | 91.86 139.17% | Perf 5Y: | -20.49% |
| Dividend Ex-Date: | - | Current Ratio: | 1.37 | EPS Y/Y TTM: | -118.96% | Oper. Margin: | 11.94% | RSI (14): | 67.48 | Volatility: | 4.45% 3.04% |
| Employees: | 20100 | Debt/Eq: | 0.77 | Sales Y/Y TTM: | -0.92% | Profit Margin: | -2.07% | Recom: | 2.05 | Target Price: | 212.64 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.77 | EPS Q/Q: | -17.30% | Payout: | 0.00% | Rel Volume: | 0.87 | Prev Close: | 223.47 |
| Sales Surprise: | 1.42% | EPS Surprise: | 3.95% | Sales Q/Q: | -0.49% | Earnings: | Nov 05 BMO | Avg Volume: | 926.86K | Price: | 219.70 |
| SMA20: | 4.98% | SMA50: | 15.46% | SMA200: | 36.15% | Overbought: 3.21% | Volume: | 803,742 | Change: | -1.69% | |
Graham Classic formula value: -26.86
(P/E=8 * 1g) Min value: -18.65
(current P/E * 2g) Max value: -15.03
Average value: -20.18
About Charles River Laboratories International Inc
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The Discovery and Safety Assessment segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.